Activity value 75kenya Buyer,Last transaction date:
2026-02-23
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for arachis pharmaceutical ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 2900 and a transaction weight of 0.
5stu
francebuyer,they trade on 2025-12-09
20.28%
>
+View All
Products
Total 190
ProductsTransactionsPerDetail
injection 16524.52%>
mg tablet 11316.79%>
inhaler 8813.08%>
tablet 8011.89%>
foracort 487.13%>
+View All
Hscode rank
Total 23
HSCode NameTransactionsPerDetail
HS 3004909961190.79%>
HS 30049079304.46%>
HS 3004320060.89%>
HS 3004907460.89%>
HS 3004391150.74%>
+View All
Trading Area
Total 6
AreaTransactionsPerDetail
india67795.62%>
england233.25%>
united states40.56%>
korea20.28%>
belgium10.14%>
+View All
Port statistics
Total 1
Port NameTransactionsPerDetail
nairobi67394.66%>
arachis pharmaceutical ltd. is kenya Buyer,
and primarily engages in the import and export business of products such as injection,mg tablet,inhaler.
According to the 52wmb.com global trade database, as of 2026-02-23, the company has completed 711 international trades,
with its main trading regions covering india,england,united states etc.
The core products include HS30049099,HS30049079,HS30043200 etc,
often transported via nairobi etc,
and its main trading partners are rushabh forex services pvt ltd.,rutva medicare,knox pharmaceuticals ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on arachis pharmaceutical ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.